Canandaigua National Trust Co of Florida Buys 342 Shares of The Procter & Gamble Company (NYSE:PG)

Canandaigua National Trust Co of Florida lifted its position in The Procter & Gamble Company (NYSE:PGFree Report) by 7.9% in the 4th quarter, Holdings Channel reports. The fund owned 4,688 shares of the company’s stock after acquiring an additional 342 shares during the quarter. Canandaigua National Trust Co of Florida’s holdings in Procter & Gamble were worth $786,000 as of its most recent SEC filing.

Several other hedge funds also recently made changes to their positions in PG. International Assets Investment Management LLC boosted its holdings in Procter & Gamble by 19,030.8% in the third quarter. International Assets Investment Management LLC now owns 3,693,593 shares of the company’s stock worth $639,730,000 after acquiring an additional 3,674,286 shares in the last quarter. Wulff Hansen & CO. boosted its stake in Procter & Gamble by 16,292.0% in the 2nd quarter. Wulff Hansen & CO. now owns 3,675,902 shares of the company’s stock worth $606,230,000 after purchasing an additional 3,653,477 shares in the last quarter. Geode Capital Management LLC grew its position in Procter & Gamble by 7.0% during the 3rd quarter. Geode Capital Management LLC now owns 55,204,776 shares of the company’s stock valued at $9,538,327,000 after purchasing an additional 3,619,466 shares during the last quarter. Franklin Resources Inc. increased its stake in Procter & Gamble by 10.2% during the 3rd quarter. Franklin Resources Inc. now owns 18,988,721 shares of the company’s stock valued at $3,290,573,000 after purchasing an additional 1,760,214 shares in the last quarter. Finally, B. Metzler seel. Sohn & Co. Holding AG bought a new position in shares of Procter & Gamble in the third quarter worth approximately $301,950,000. 65.77% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other Procter & Gamble news, CEO Gary A. Coombe sold 47,847 shares of the stock in a transaction on Wednesday, November 27th. The shares were sold at an average price of $179.84, for a total transaction of $8,604,804.48. Following the completion of the transaction, the chief executive officer now owns 39,977 shares in the company, valued at $7,189,463.68. This trade represents a 54.48 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Balaji Purushothaman sold 12,800 shares of the company’s stock in a transaction dated Thursday, November 21st. The shares were sold at an average price of $172.73, for a total transaction of $2,210,944.00. Following the sale, the insider now owns 11,595 shares in the company, valued at $2,002,804.35. This represents a 52.47 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 75,439 shares of company stock worth $13,317,460. Corporate insiders own 0.18% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on PG. Barclays lowered shares of Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price objective for the company. in a report on Monday, September 30th. Piper Sandler initiated coverage on Procter & Gamble in a research report on Tuesday, September 24th. They set a “neutral” rating and a $174.00 price objective on the stock. Hsbc Global Res raised Procter & Gamble to a “strong-buy” rating in a research report on Friday, October 4th. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $164.00 price target on shares of Procter & Gamble in a report on Monday, October 21st. Finally, Morgan Stanley boosted their price objective on shares of Procter & Gamble from $174.00 to $191.00 and gave the company an “overweight” rating in a report on Monday, October 21st. Eight investment analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $180.45.

Read Our Latest Stock Report on PG

Procter & Gamble Price Performance

Shares of NYSE:PG traded down $4.52 during trading on Monday, hitting $160.61. 8,538,484 shares of the company’s stock were exchanged, compared to its average volume of 5,385,503. The business’s 50-day simple moving average is $170.21 and its 200 day simple moving average is $169.85. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.75 and a quick ratio of 0.55. The Procter & Gamble Company has a 52-week low of $146.28 and a 52-week high of $180.43. The company has a market cap of $378.24 billion, a price-to-earnings ratio of 27.69, a PEG ratio of 3.70 and a beta of 0.45.

Procter & Gamble (NYSE:PGGet Free Report) last released its earnings results on Friday, October 18th. The company reported $1.93 EPS for the quarter, topping the consensus estimate of $1.90 by $0.03. The firm had revenue of $21.74 billion for the quarter, compared to the consensus estimate of $21.99 billion. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The company’s quarterly revenue was down .6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.83 earnings per share. As a group, equities analysts predict that The Procter & Gamble Company will post 6.94 EPS for the current year.

Procter & Gamble Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were issued a $1.0065 dividend. The ex-dividend date was Friday, October 18th. This represents a $4.03 annualized dividend and a dividend yield of 2.51%. Procter & Gamble’s dividend payout ratio (DPR) is 69.31%.

Procter & Gamble Profile

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Featured Articles

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.